Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07312370) titled 'Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing: A Randomized Controlled Trial' on Dec. 17, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: LanZhou University
Condition:
Early Gastric Cancer
Gastric Dysplasia
Gastric Neoplasms
Peptic Ulcer With Haemorrhage
Gastric Ulcer
Intervention:
Drug: Esomeprazole (Intravenous)
Drug: Esomeprazole (Oral)
Drug: Sucralfate Suspension
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: January 20,...